Bio-Rad Laboratories (BIO-B) Short-term Investments (2009 - 2026)

Bio-Rad Laboratories (BIO-B) has 18 years of Short-term Investments data on file, last reported at $1.1 billion in Q1 2026.

• Short-term Investments for Q1 2026 came in at $1.1 billion, down 7.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 7.16% YoY), and the FY2025 annual result was $1.0 billion, down 14.07% from the prior year.
• Short-term Investments improved to $1.1 billion in Q1 2026 per BIO-B's latest filing, from $1.0 billion in the prior quarter.
• Over five years, Short-term Investments peaked at $1.3 billion in Q2 2023 and troughed at $5.6 million in Q2 2022.
• A 5-year average of $604.0 million and a median of $1.0 billion in 2025 frame the typical range for Short-term Investments.
• On a YoY basis, Short-term Investments climbed as much as 23869.15% in 2023 and fell as far as 99.56% in 2023.
• A 5-year view of Short-term Investments shows it stood at $5.6 million in 2022, then changed by 0.0% to $5.6 million in 2023, then jumped by 20907.14% to $1.2 billion in 2024, then retreated by 14.07% to $1.0 billion in 2025, then advanced by 4.61% to $1.1 billion in 2026.
• Business Quant data shows BIO-B's Short-term Investments at $1.1 billion in Q1 2026, $1.0 billion in Q4 2025, and $1.0 billion in Q3 2025.